Paul Oyalo
Paul Oyalo joined the OHE in August 2024 as Graduate Economist. Before joining us, Paul had previously worked on various research projects focusing on improving patient access to cancer therapies in Low- and Middle-income countries.
Paul holds an MSc in Health Economics and Decision Modelling from the University of Sheffield and has previously completed a Post-Graduate Certificate in Global Health and Epidemiology from the University of Dundee. For his master’s dissertation, he carried out an empirical de-novo cost-effective analysis for the treatment of the rare adult-onset dermatomyositis in UK population. Paul’s research interests are in cost effectiveness modelling, the economic evaluation of rare diseases, and pricing strategies for innovative therapies.
Publications and Insights
- Publication: The economic burden of overweight and obesity in Europe
- Insight: Around the World in HTAs: Zimbabwe – Seizing a window of opportunity
- Publication: Unlocking the broader value of biologic therapies through biosimilar-enabled access and repositioning
- Insight: Around the World in HTAs: Kenya – Riding the Waves of Change
- Publication: Challenges and Solutions for Budget Impact Analysis of Gene Therapies
- Insight: Advancing Rare Disease Care: Challenges and Key Issues